Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt Becomes Maiden Licensee to OGS Automated-Proteomics Technology

NEW YORK, Feb. 8 - Oxford GlycoSciences on Friday said that GeneProt has licensed a pair of patents to its automated proteomics technology. 


The licenses, for US Patents Nos. 6,064,754 and 6,278,794, cover "the use of methods and apparatus for computer-assisted selection and robotic isolation of proteins following two‑dimensional separation," the companies said in a joint statement.


Under the terms of the seven-year, non-exclusive agreement, GeneProt, which becomes the first company to license the technologies, will pay OGS an up-front licensing fee of $1 million in cash and equity. The firm will also shell out additional annual payments that will depend on the status of patents in the US, Europe, and Japan. 


Other terms of the deal were not disclosed.


"This licensing agreement will give GeneProt the freedom to operate under the patents licensed for the provision of proteomics services," the companies said. "No transfer of technology, know-how or trade secrets will occur under the terms of this transaction."


On Thursday, UK-based OGS said it has opened a US office that will focus on specialty biopharmaceuticals. The new facility in Bridgewater, NJ, will be home to OGS' commercial team, headed by Lou Ferrari, vice president of global marketing.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.